![]() | Up a level |
McWilliam, SJ ORCID: 0000-0002-0509-7425, Antoine, DJ, Smyth, RL and Pirmohamed, M
ORCID: 0000-0002-7534-7266
(2017)
Aminoglycoside-induced nephrotoxicity in children.
Pediatric Nephrology, 32 (11).
2015 - 2025.
Clarke, JI, Forootan, SS, Lea, JD, Howell, LS, Rodriguez, JM, Kipar, A ORCID: 0000-0001-7289-3459, Goldring, CE, Park, BK
ORCID: 0000-0001-8384-824X, Copple, IM
ORCID: 0000-0003-4101-1913 and Antoine, DJ
(2017)
Circulating levels of miR-122 increase post-mortem, particularly following lethal dosing with pentobarbital sodium: implications for pre-clinical liver injury studies.
TOXICOLOGY RESEARCH, 6 (4).
406 - 411.
Qin, S, Zhou, Y, Gray, L, Kusebauch, U, McEvoy, L ORCID: 0000-0002-2169-6735, Antoine, DJ, Hampson, L, Park, BK
ORCID: 0000-0001-8384-824X, Campbell, DS, Caballero, J et al (show 10 more authors)
(2016)
Identification of Organ-Enriched Protein Biomarkers of Acute Liver Injury by Targeted Quantitative Proteomics of Blood in Acetaminophen- and Carbon-Tetrachloride-Treated Mouse Models and Acetaminophen Overdose Patients.
Journal of proteome research, 15 (10).
3724 - 3740.
McWilliam, SJ ORCID: 0000-0002-0509-7425, Antoine, DJ, Sabbisetti, V, Turner, MA, Farragher, T, Bonventre, JV, Park, BK, Smyth, RL and Pirmohamed, M
(2012)
Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: A proof-of-concept study.
PLoS One, 7.
e43909 - ?.
Oni, L ORCID: 0000-0002-1532-2390, Hawcutt, DB
ORCID: 0000-0002-8120-6507, Turner, MA
ORCID: 0000-0002-5299-8656, Beresford, MW
ORCID: 0000-0002-5400-9911, McWilliam, S
ORCID: 0000-0002-0509-7425, Barton, C, Park, BK
ORCID: 0000-0001-8384-824X, Murray, P, Wilm, B
ORCID: 0000-0002-9245-993X, Copple, I
ORCID: 0000-0003-4101-1913 et al (show 4 more authors)
(2017)
Optimising the use of medicines to reduce acute kidney injury in children and babies.
Pharmacology and Therapeutics, 174.
55 - 62.
McWilliam, SJ ORCID: 0000-0002-0509-7425, Antoine, DJ, Rosala-Hallas, A
ORCID: 0000-0001-8012-9995, Jones, A, MacLean, C, Prayle, A, Smyth, AR, Flaherty, L, Shaw, VE, Greenhalf, W et al (show 2 more authors)
(2017)
THE PROTEKT STUDY - A PHASE IIA, RANDOMISED, CONTROLLED, OPEN-LABEL TRIAL OF ROSUVASTATIN FOR THE PREVENTION OF AMINOGLYCOSIDE-INDUCED KIDNEY TOXICITY IN CHILDREN WITH CYSTIC FIBROSIS.
In: 31st Annual North American Cystic Fibrosis Conference, 2017-11-02 - 2017-11-04, Indiana Convention Center, Indianapolis, Indiana.
Walker, L ORCID: 0000-0002-3827-4387, Griffiths, MJ, McGill, F, Lewthwaite, P, Sills, GJ
ORCID: 0000-0002-3389-8713, Jorgensen, A, Antoine, DJ, Solomon, T
ORCID: 0000-0001-7266-6547, Marson, AG
ORCID: 0000-0002-6861-8806 and Pirmohamed, M
ORCID: 0000-0002-7534-7266
(2016)
A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease.
Biomarkers, 22 (7).
635 - 642.
Lundback, P, Lea, JD, Sowinska, A, Ottosson, L, Furst, CM, Steen, J, Aulin, C, Clarke, JI, Kipar, A ORCID: 0000-0001-7289-3459, Klevenvall, L et al (show 8 more authors)
(2016)
A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice.
Hepatology, 64 (5).
1699 - 1710.